154 related articles for article (PubMed ID: 23670235)
1. Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751.
Innocenti F; Ramírez J; Obel J; Xiong J; Mirkov S; Chiu YL; Katz DA; Carr RA; Zhang W; Das S; Adjei A; Moyer AM; Chen PX; Krivoshik A; Medina D; Gordon GB; Ratain MJ; Sahelijo L; Weinshilboum RM; Fleming GF; Bhathena A
Pharmacogenet Genomics; 2013 Jul; 23(7):374-81. PubMed ID: 23670235
[TBL] [Abstract][Full Text] [Related]
2. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients.
Sparks R; Ulrich CM; Bigler J; Tworoger SS; Yasui Y; Rajan KB; Porter P; Stanczyk FZ; Ballard-Barbash R; Yuan X; Lin MG; McVarish L; Aiello EJ; McTiernan A
Breast Cancer Res; 2004; 6(5):R488-98. PubMed ID: 15318931
[TBL] [Abstract][Full Text] [Related]
3. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7.
Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ
Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935
[TBL] [Abstract][Full Text] [Related]
4. Multiple UDP-Glucuronosyltransferase and Sulfotransferase Enzymes are Responsible for the Metabolism of Verproside in Human Liver Preparations.
Kim JH; Hwang DK; Moon JY; Lee Y; Yoo JS; Shin DH; Lee HS
Molecules; 2017 Apr; 22(4):. PubMed ID: 28441724
[TBL] [Abstract][Full Text] [Related]
5. Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.
Brand W; Boersma MG; Bik H; Hoek-van den Hil EF; Vervoort J; Barron D; Meinl W; Glatt H; Williamson G; van Bladeren PJ; Rietjens IM
Drug Metab Dispos; 2010 Apr; 38(4):617-25. PubMed ID: 20056724
[TBL] [Abstract][Full Text] [Related]
6. Sulfotransferase gene copy number variation: pharmacogenetics and function.
Hebbring SJ; Moyer AM; Weinshilboum RM
Cytogenet Genome Res; 2008; 123(1-4):205-10. PubMed ID: 19287157
[TBL] [Abstract][Full Text] [Related]
7. Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1.
Ung D; Nagar S
Drug Metab Dispos; 2007 May; 35(5):740-6. PubMed ID: 17293380
[TBL] [Abstract][Full Text] [Related]
8. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.
Stingl JC; Bartels H; Viviani R; Lehmann ML; Brockmöller J
Pharmacol Ther; 2014 Jan; 141(1):92-116. PubMed ID: 24076267
[TBL] [Abstract][Full Text] [Related]
9. Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.
Yong M; Schwartz SM; Atkinson C; Makar KW; Thomas SS; Newton KM; Aiello Bowles EJ; Holt VL; Leisenring WM; Lampe JW
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):537-46. PubMed ID: 20142249
[TBL] [Abstract][Full Text] [Related]
10. UGT genotyping in belinostat dosing.
Goey AK; Figg WD
Pharmacol Res; 2016 Mar; 105():22-7. PubMed ID: 26773202
[TBL] [Abstract][Full Text] [Related]
11. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
Shatalova EG; Loginov VI; Braga EA; Kazubskaia TP; Sudomoina MA; Blanchard RL; Favorova OO
Mol Biol (Mosk); 2006; 40(2):263-70. PubMed ID: 16637266
[TBL] [Abstract][Full Text] [Related]
12. Profiles and Gender-Specifics of UDP-Glucuronosyltransferases and Sulfotransferases Expressions in the Major Metabolic Organs of Wild-Type and Efflux Transporter Knockout FVB Mice.
Chen J; Zheng H; Zeng S; Xie C; Li X; Yan T; Gong X; Lu L; Qi X; Wang Y; Hu M; Zhu L; Liu Z
Mol Pharm; 2017 Sep; 14(9):2967-2976. PubMed ID: 28661152
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants.
Erickson-Ridout KK; Zhu J; Lazarus P
Pharmacogenet Genomics; 2011 Sep; 21(9):539-51. PubMed ID: 21750471
[TBL] [Abstract][Full Text] [Related]
14. Glucuronidation of the second-generation antipsychotic clozapine and its active metabolite N-desmethylclozapine. Potential importance of the UGT1A1 A(TA)₇TAA and UGT1A4 L48V polymorphisms.
Erickson-Ridout KK; Sun D; Lazarus P
Pharmacogenet Genomics; 2012 Aug; 22(8):561-76. PubMed ID: 22565219
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study.
Shatalova EG; Walther SE; Favorova OO; Rebbeck TR; Blanchard RL
Breast Cancer Res; 2005; 7(6):R909-21. PubMed ID: 16280036
[TBL] [Abstract][Full Text] [Related]
16. Cancer and molecular biomarkers of phase 2.
Dalhoff K; Buus Jensen K; Enghusen Poulsen H
Methods Enzymol; 2005; 400():618-27. PubMed ID: 16399374
[TBL] [Abstract][Full Text] [Related]
17. First chemical synthesis and in vitro characterization of the potential human metabolites 5-o-feruloylquinic acid 4'-sulfate and 4'-O-glucuronide.
Menozzi-Smarrito C; Wong CC; Meinl W; Glatt H; Fumeaux R; Munari C; Robert F; Williamson G; Barron D
J Agric Food Chem; 2011 May; 59(10):5671-6. PubMed ID: 21417257
[TBL] [Abstract][Full Text] [Related]
18. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin.
Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T
Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534
[TBL] [Abstract][Full Text] [Related]
19. Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes.
Fang JL; Beland FA; Doerge DR; Wiener D; Guillemette C; Marques MM; Lazarus P
Cancer Res; 2002 Apr; 62(7):1978-86. PubMed ID: 11929814
[TBL] [Abstract][Full Text] [Related]
20. Phase II metabolism of betulin by rat and human UDP-glucuronosyltransferases and sulfotransferases.
Hu Z; Wang Z; Luo S; James MO; Wang Y
Chem Biol Interact; 2019 Apr; 302():190-195. PubMed ID: 30776358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
